PUBLISHER: Grand View Research | PRODUCT CODE: 1433552
PUBLISHER: Grand View Research | PRODUCT CODE: 1433552
The Europe digestive health supplements market size is expected to reach USD 7.07 billion by 2030 and is anticipated to grow at a CAGR of 8.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of digestive issues can be attributed to sedentary lifestyles, adopting Western diets rich in processed foods, and the increasing stressors of modern life. It includes conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Diseases (IBD), acid reflux, and functional dyspepsia, which have become increasingly common and are affecting a significant portion of the European population.
According to a report by United European Gastroenterology (UEG) in 2023, Gastrointestinal (GI) and liver disorders have a significant impact on the people of Europe, causing nearly one million deaths each year across all age groups. These conditions are associated with morbidity and healthcare expenses. The incidence and prevalence of many GI disorders are highest among the young and elderly, and as Europe's population ages, the disease burden is expected to increase.
The European region is home to over 332 million individuals affected by digestive disorders. In 31 countries with available data, digestive disease-related morbidity results in a loss of output equal to 0.22% of GDP, while premature mortality accounts for 0.25%. The report suggests that reducing digestive disease-related premature deaths by 25% in 2019 could have prevented productivity losses worth EURO 11.4 billion in 31 countries.
The European digestive health supplement market is influenced by the increasing awareness of the gut microbiome's role in weight regulation. The gut microbiome extracts energy from food, regulates metabolism, and stores and distributes fat. As a result, digestive health supplements, particularly those enriched with probiotics, are becoming crucial tools in addressing this awareness. Probiotics are live microorganisms, often beneficial bacteria that offer health benefits when consumed in sufficient quantities. In the context of weight regulation, specific probiotic strains have been linked to positive changes in gut microbiota composition, affecting factors such as inflammation, energy metabolism, and fat storage. The targeted supplementation of these probiotics is a precise method of regulating the microbiome to achieve weight-related objectives.